Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260).
2026 · 3rd Quarter (July 1 - Sep 30)
BIOSPLICE THERAPEUTICS, INC.
Filed by AKIN GUMP STRAUSS HAUER & FELD.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $110,000.00
- Expenses
- Not reported
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Filing UUID
- 7793265f-10da-4ed1-9cc6-df8ee025838b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.